Abstract
Purpose
To evaluate the predictive role of maternal urinary CA 19-9 as a non-invasive marker for diagnosing antenatal posterior urethral valve (PUV).
Methods
A total of 40 women in the third pregnancy trimester were enrolled. Case group (group A) consisted of 20 women with a diagnosis of antenatal PUV. Twenty women with similar gestational age, fetal sex, normal US, and no history of congenital anomalies were chosen as a control group (group B). Maternal urine samples were collected and urinary CA 19-9 was measured in both groups. The correlations between maternal urinary CA 19-9 and APD (measured during pregnancy and the initial evaluation of the newborn) were assessed. CA 19-9 level in first urine of neonates was also evaluated.
Results
The mean ± SD of maternal urine CA 19-9 was higher in PUV group compared to the control group (131.6 ± 23.8 vs. 13 ± 2.7 U/mL). In addition, there was a significant correlation between maternal urinary CA 19-9 and the APD measured at the third trimester (p < 0.001) and the initial evaluation of fetus after birth according to SFU grading system (p < 0.001). However, no significant difference was found between gestational age and urinary CA 19-9 level (p = 0.34). There was also a significant correlation between the CA 19-9 level in first urine of neonates and CA 19-9 level of maternal urine (p < 0.001).
Conclusions
This is the first time that maternal urinary CA 19-9 has been applied as a noninvasive and practical diagnostic marker in antenatal PUV.
Similar content being viewed by others
Abbreviations
- ANH:
-
Antenatal hydronephrosis
- APD:
-
Anteroposterior renal pelvic diameter
- CA 19-9:
-
Carbohydrate antigen
- SFU:
-
Society for Fetal Urology
References
Brown T, Mandell J, Lebowitz RL (1987) Neonatal hydronephrosis in the era of sonography. AJR Am J Roentgenol 148(5):959–963. https://doi.org/10.2214/ajr.148.5.959
DeFoor W, Clark C, Jackson E, Reddy P, Minevich E, Sheldon C (2008) Risk factors for end stage renal disease in children with posterior urethral valves. J Urol 180(4 Suppl):1705–1708. https://doi.org/10.1016/j.juro.2008.03.090 (discussion 1708)
Sarhan O, Zaccaria I, Macher MA, Muller F, Vuillard E, Delezoide AL, Sebag G, Oury JF, Aigrain Y, El-Ghoneimi A (2008) Long-term outcome of prenatally detected posterior urethral valves: single center study of 65 cases managed by primary valve ablation. J Urol 179(1):307–312. https://doi.org/10.1016/j.juro.2007.08.160 (discussion 312–303)
Sidhu G, Beyene J, Rosenblum ND (2006) Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis. Pediatr Nephrol 21(2):218–224
Nguyen HT, Herndon CA, Cooper C, Gatti J, Kirsch A, Kokorowski P, Lee R, Perez-Brayfield M, Metcalfe P, Yerkes E (2010) The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 6(3):212–231
Sinha A, Bagga A, Krishna A, Bajpai M, Srinivas M, Uppal R, Agarwal I (2013) Revised guidelines on management of antenatal hydronephrosis. Indian J Nephrol 23(2):83–97. https://doi.org/10.4103/0971-4065.109403
Noyan A, Parmaksiz G, Dursun H, Ezer SS, Anarat R, Cengiz N (2015) Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis. J Pediatr Urol 11(5):249. e241–249. e246
Suzuki K, Muraishi O, Tokue A (2002) The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis. J Urol 167(1):16–20
Ohshio G, Ogawa K, Kudo H, Yamabe H, Higuchi K, Nakashima Y, Manabe T, Tobe T (1990) Immunohistochemical distribution of CA 19-9 in normal and tumor tissues of the kidney. Urol Int 45(1):1–3
Kajbafzadeh AM, Keihani S, Kameli SM, Hojjat A (2017) Maternal urinary carbohydrate antigen 19-9 as a novel biomarker for evaluating fetal hydronephrosis: a pilot study. Urol 101:90–93. https://doi.org/10.1016/j.urology.2016.10.038
Bhadoo D, Bajpai M, Abid A, Sukanya G, Agarwala S, Srinivas M, Deka D, Agarwal N, Agarwal R, Kumar R (2015) Study of prognostic significance of antenatal ultrasonography and renin angiotensin system activation in predicting disease severity in posterior urethral valves. J Indian Assoc Pediatr Surg 20(2):63–67. https://doi.org/10.4103/0971-9261.151546
Lopez Pereira P, Martinez Urrutia MJ, Espinosa L, Jaureguizar E (2013) Long-term consequences of posterior urethral valves. J Pediatr Urol 9(5):590–596. https://doi.org/10.1016/j.jpurol.2013.06.007
Simoes e Silva AC, Valerio FC, Vasconcelos MA, Miranda DM, Oliveira EA (2013) Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease. Clin Dev Immunol 2013:597920. https://doi.org/10.1155/2013/597920
Surange RS, Jeygopal NS, Chowdhury SD, Sharma NK (2001) Bedside ultrasound: a useful tool for the on-call urologist? Int Urol Nephrol 32(4):591–596
Vemulakonda V, Wilcox D, Torok M, Hou A, Campbell J, Kempe A (2015) Inter-rater reliability of postnatal ultrasound interpretation in infants with congenital hydronephrosis. Int Urol Nephrol 47(9):1457–1461
Assadi F, Schloemer N (2012) Simplified diagnostic algorithm for evaluation of neonates with prenatally detected hydronephrosis. Iran J Kidney Dis 6(4):284
Docimo SG, Silver RI (1997) Renal ultrasonography in newborns with prenatally detected hydronephrosis: why wait? J Urol 157(4):1387–1389
González R, Schimke CM (2001) Urteropelvic junction obstruction in infants and children. Pediatr Clin N Am 48(6):1505–1518
Rickard M, Easterbrook B, Kim S, Farrokhyar F, Stein N, Arora S, Belostotsky V, DeMaria J, Lorenzo AJ, Braga LH (2017) Six of one, half a dozen of the other: a measure of multidisciplinary inter/intra-rater reliability of the society for fetal urology and urinary tract dilation grading systems for hydronephrosis. J Pediatr Urol 13(1):80 e81–80 e85. https://doi.org/10.1016/j.jpurol.2016.09.005
Aybek H, Aybek Z, Sinik Z, Demir S, Sancak B, Tuncay L (2006) Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. Int J Urol 13(11):1380–1384
Suzuki K (2007) Elevation of serum and urinary carbohydrate antigen 19-9 in benign hydronephrosis. Int J Urol 14(7):668–669
Khorramirouz R, Ebadi M, Rahimi Sherbaf F, Kajbafzadeh A-M (2014) Persistent high level of urinary tumor marker carbohydrate antigen 19–9 in prenatally diagnosed dysplastic kidney. Case Rep Urol 2014:259870
Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC (2015) The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis. J Pediatr Urol 11(3):133. e131–133. e135
Suzuki K (2000) Renal pelvic and ureteral cancer with extremely high serum level of carbohydrate antigen 19-9 (CA 19-9): a case report. Nishi Nihon J Urol 62(12):659–663
Arik N, Adam B, Akpolat T, Hasil K, Tabak S (1996) Serum tumour markers in renal failure. Int Urol Nephrol 28(4):601–604
Kajbafzadeh A-M, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P (2010) Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. J Urol 183(6):2353–2360
Kutlu O, Celik O, Koksal I, Yigit S, Danisman A (2012) Serum carbohydrate antigen 19-9 levels in patients with unilateral hydronephrosis due to urinary lithiasis. Minerva Urol Nefrol 64(3):217–221
Muller F, Dommergues M, Mandelbrot L, Aubry M-C, Nihoul-Fekete C, Dumez Y (1993) Fetal urinary biochemistry predicts postnatal renal function in children with bilateral obstructive uropathies. Obstetr Gynecol 82(5):813–820
Kajbafzadeh A, Elmi A, Talab SS, Tourchi A, Abdaresfahani S (2010) Fetal urinary new biomarker for prediction of renal and pulmonary function in posterior urethral valves. J Pediatr Urol 6:S46–S47
Funding
None of the authors has direct or indirect commercial financial incentive associating with publishing the article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has direct or indirect commercial financial incentive associated with publishing the article and does not have any conflict of interest, and will sign the Disclosing Form.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix: SFU grading description
Appendix: SFU grading description
Grade | Description |
---|---|
Grade 0 | No dilatation of the renal pelvis |
Grade I | Mild dilatation of the renal pelvis (without dilatation of the calyces) |
Grade II | Mild dilatation of the renal pelvis and calyces without parenchymal atrophy |
Grade III | Moderate dilatation of the renal pelvis and calyces with mild cortical thinning |
Grade IV | Gross dilatation of the renal pelvis and calyces plus thinning of the renal parenchyma |
Rights and permissions
About this article
Cite this article
Kajbafzadeh, AM., Sabetkish, S. & Sabetkish, N. Prognostic significance of maternal urinary carbohydrate antigen 19-9 for antenatal diagnosis of posterior urethral valve associated with fetal hydronephrosis. Int Urol Nephrol 51, 909–915 (2019). https://doi.org/10.1007/s11255-019-02138-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-019-02138-w